Nov 17, 2020 7:00 am EST Castle Biosciences Announces Publication of Clinical Validation and Utility Data for DecisionDx® DiffDx™-Melanoma for Suspicious Pigmented Lesions
Nov 12, 2020 7:00 am EST Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx® DiffDx™-Melanoma Tests at American Society of Dermatopathology (ASDP) 57th Virtual Annual Meeting
Nov 5, 2020 7:00 am EST Castle Biosciences to Present at the Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
Oct 29, 2020 7:00 am EDT Castle Biosciences to Present Data at the American Society of Dermatopathology (ASDP) 57th Virtual Annual Meeting
Oct 26, 2020 7:00 am EDT Castle Biosciences to Release Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 9, 2020
Oct 21, 2020 7:00 am EDT Castle Biosciences to Hold Webcast for Investors Highlighting Commercial Launch of ConfirmDx®-Melanoma
Oct 16, 2020 7:00 am EDT Castle Biosciences Presents Data on DecisionDx-Melanoma at the Virtual European Association of Dermato-Oncology (EADO) Congress
Oct 12, 2020 7:00 am EDT Castle Biosciences Presents Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
